US Broker Ratings

Charles River Laboratories (CRL) Stock Analysis: Exploring the 27% Upside Potential

Charles River Laboratories International, Inc. (NYSE: CRL) presents a compelling opportunity for investors intrigued by the healthcare sector’s diagnostics and research segment. With a market capitalization..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: An Investor Outlook with a Staggering 218% Potential Upside

Soleno Therapeutics, Inc. (SLNO), a biopharmaceutical firm based in Redwood City, California, is drawing significant attention from investors, both for its innovative approach to treating rare..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: A Biotech Powerhouse with 42.53% Potential Upside

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is capturing investor attention with a compelling potential upside of 42.53%, making it a standout in the biotechnology sector. This New..

Globus Medical, Inc. (GMED) Stock Analysis: A 28.95% Potential Upside Beckons Investors

Globus Medical, Inc. (NASDAQ: GMED), a formidable player in the healthcare sector, specifically within the medical devices industry, is presenting an intriguing opportunity for investors with..

Alkermes plc (ALKS) Stock Analysis: Evaluating a 57% Upside Potential

Alkermes plc (NASDAQ: ALKS), an Ireland-based biopharmaceutical company, stands out in the healthcare sector with its diversified portfolio of pharmaceutical products targeting unmet medical needs. With..

DaVita Inc. (DVA) Stock Analysis: Evaluating the Healthcare Giant’s 64.85% ROE and Future Potential

DaVita Inc. (NYSE: DVA), a stalwart in the healthcare sector, operates at the forefront of providing essential kidney dialysis services across the United States. With a..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Exploring a 52.53% Potential Upside in Biotechnology

Cytokinetics, Incorporated (NASDAQ: CYTK) is a prominent player in the healthcare sector, specifically within the biotechnology industry. Headquartered in South San Francisco, California, the company is..

Vaxcyte, Inc. (PCVX) Investor Outlook: Exploring a Potential 99.71% Upside

For investors keeping a close watch on the biotechnology sector, Vaxcyte, Inc. (NASDAQ: PCVX) presents a compelling case. With a market capitalization of approximately $7.93 billion,..

Illumina, Inc. (ILMN) Stock Analysis: Potential 14.39% Upside Amidst Strong Revenue Growth

Illumina, Inc. (NASDAQ: ILMN), a powerhouse in the healthcare sector, is a leader in diagnostics and research with a market capitalization of $18.19 billion. Headquartered in..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Exploring a 60.98% Potential Upside in the Biotech Arena

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands at the forefront of biopharmaceutical innovation, focusing on rare neuroendocrine diseases with its pioneering product, IMCIVREE (setmelanotide). With a market..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: A Compelling 33.48% Upside Potential

Teva Pharmaceutical Industries Limited (NYSE: TEVA) is a major player in the healthcare sector, specializing in both specialty and generic drug manufacturing. With its headquarters in..

Qiagen N.V. (QGEN) Investor Outlook: Strong Buy Ratings and a 36% Potential Upside

In the fast-evolving world of diagnostics and research, Qiagen N.V. (NASDAQ: QGEN) stands as a prominent player with a market capitalization of $8.37 billion. Headquartered in..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating Growth Amidst Volatility with a 31.60% Upside Potential

Inspire Medical Systems, Inc. (NASDAQ: INSP), a key player in the medical devices industry, has been making waves with its innovative solutions for obstructive sleep apnea..

Boston Scientific Corporation (BSX) Stock Analysis: Unpacking a 50% Potential Upside

Boston Scientific Corporation (NYSE: BSX) is a heavyweight in the healthcare sector, specifically within the medical devices industry. With a commanding market cap of $102.58 billion,..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Exploring a 36% Potential Upside in Biotech

Revolution Medicines, Inc. (NASDAQ: RVMD) is making waves in the biotechnology sector with its innovative approach to combating RAS-addicted cancers. With a market capitalization of $18.8..

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring a 36.88% Potential Upside

Option Care Health, Inc. (NASDAQ: OPCH), a prominent player in the healthcare sector, operates within the medical care facilities industry. Based in Bannockburn, Illinois, the company..

Revvity, Inc. (RVTY) Stock Analysis: Exploring a Promising 39.72% Upside in Healthcare Diagnostics

Revvity, Inc. (NYSE: RVTY), a stalwart in the healthcare diagnostics landscape, has captured investor interest with its intriguing blend of robust product offerings and a significant..

CVS Health Corporation (CVS) Stock Analysis: A Healthcare Giant with 26.76% Upside Potential

CVS Health Corporation (NYSE: CVS), a prominent player in the healthcare sector, is capturing investor attention with a compelling 26.76% potential upside, according to analyst consensus...

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Can This Biotech Pioneer Rebound from Its Recent Lows?

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) has long been a beacon of hope in the biotechnology sector, primarily focusing on innovative treatments for rare diseases such as..

Natera, Inc. (NTRA) Stock Analysis: Insights on Its 38.75% Potential Upside

Natera, Inc. (NTRA), a leader in the diagnostics and research industry, has caught the attention of investors with its promising growth metrics and robust market position...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds